One-step, three-component synthesis of pyridines and 1,4-dihydropyridines with manifold medicinal utility

Organic Letters

Volumn 8, Issue 5, 2006, Pages 899-902

  Evdokimov, Nikolai M ^a   Magedov, Igor V ^a,b   Kireev, Artem S ^c   Kornienko, Alexander ^c  

^a RUSSIAN STATE AGRARIAN UNIVERSITY   (Russian Federation)

^b Intelbioscan Ltd   (Russian Federation)

^c NEW MEXICO INSTITUTE OF MINING AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DIHYDROPYRIDINE DERIVATIVE; NITRILE; PYRIDINE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; COMBINATORIAL CHEMISTRY; OXIDATION REDUCTION REACTION; SYNTHESIS;

ANTI-INFLAMMATORY AGENTS; COMBINATORIAL CHEMISTRY TECHNIQUES; DIHYDROPYRIDINES; MOLECULAR STRUCTURE; NITRILES; OXIDATION-REDUCTION; PYRIDINES;

EID: 33644947717     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol052994+     Document Type: Article

References (35)

1. For recent reviews, see: (a) Ramón, D. J.; Miguel, Y. Angew. Chem., Int. Ed. 2005, 44, 1602-1634.
2. (b) Orru, R. V. A.; de Greef, M. Synthesis 2003, 1471-1499.
3. (c) Ugi, I.; Heck, S. Comb. Chem. High Throughput Screening 2001, 4, 1-34.
4. (d) Weber, L.; Illgen, K.; Almstetter, M. Synlett 1999, 366-374.
5. (a) The term "privileged scaffolds or structures" was originally introduced by Merck researchers in their work on benzodiazepines: Evans, B. E. et al. J. Med. Chem. 1988, 31, 2235-2246.
6. (b) For a recent review, see: Patchett, A. A.; Nargund, R. P. Ann. Rep. Med. Chem. 2000, 35, 289-298.
7. (a) Anderson, D. R.; Stehle, N. W.; Kolodziej, S. A.; Reinhard, E. J. PCT Int. Appl. WO 2004055015 A1 20040701, 2004.
8. (b) Nirschl, A. A.; Hamann, L. G. US Pat. Appl. Publ. US 2005182105 A1 20050818, 2005.
9. (c) Harada, H.; Watanuki, S.; Takuwa, T.; Kawaguchi, K.; Okazaki, T.; Hirano, Y.; Saitoh, C. PCT Int. Appl. WO 2002006237 A1 20020124, 2002.
10. (d) Chen, H.; Zhang, W.; Tam, R.; Raney, A. K. PCT Int. Appl. WO 2005058315 A1 20050630, 2005.
11. (e) Levy, S. B.; Alekshun, M. N.; Podlogar, B. L.; Ohemeng, K.; Verma, A. K.; Warchol, T.; Bhatia, B.; Bowser, T.; Oder, M. US Pat. Appl. Publ. US 2005124678 A1 20050609, 2005.
12. Perrier, V.; Wallace, A. C.; Kaneko, K.; Safar, J.; Prusiner, S. B.; Cohen, F. E. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 6073-6078.
13. Beukers, M. W.; Chang, L. C. W.; von Frijtag Drabbe Künzel, J. K.; Mulder-Krieger, T.; Spanjersberg, R. F.; Brussee, J.; Ijzerman, A. P. J. Med. Chem. 2004, 47, 3707-3709.
14. Chang, L. C. W.; von Frijtag Drabbe Künzel, J. K.; Mulder-Krieger, T.; Spanjersberg, R. F.; Roerink, S. F.; van den Hout, G.; Beukers, M. W.; Brussee, J.; Ijzerman, A. P. J. Med. Chem. 2005, 48, 2045-2053.
15. Fredholm, B. B.; Ijzerman, A. P.; Jacobson, K. A.; Klotz, K.-N.; Linden, J. Pharmacol. Rev. 2001, 53, 527-552.
16. (a) Kambe, S.; Saito, K. Synthesis 1981, 531-533.
17. (b) Matrosova, S. V.; Zav'yalova, V. K.; Litvinov, V. P.; Sharanin, Y. A. Izv. Akad. Nauk SSSR, Ser. Khim. 1991, 1643-1646.
18. (c) Elnagdi, M. H.; Elghandour, A. H. H.; Ibrahim, M. K. A.; Hafiz, I. S. A. Z. Naturforsch. 1992, 47b, 572-578.
19. (d) Dyachenko, V. D.; Krivokolysko, S. G.; Nesterov, V. N.; Litvinov, V. P. Chem. Heterocycl. Comp. 1997, 33, 1430-1437.
20. (e) Dyachenko, V. D.; Litvinov, V. P. Chem. Heterocycl. Compd. 1998, 34, 188-194.
21. (f) Dyachenko, V. D.; Litvinov, V. P. Russ. J. Org. Chem. 1998, 34, 557-563.
22. (g) Quintela J. M.; Peinador, C.; Veiga, M. C.; Botana, L. M.; Alfonso, A.; Riguera, R. Eur. J. Med. Chem. 1998, 33, 887-897.
23. (h) Attia, A. M. E.; Ismail, A. El-H A. A. Tetrahedron 2003, 59, 1749-1752.
24. See also refs 5 and 6.
25. For a review of classical, such as the Hantzsch reaction, and recently developed multicomponent routes to functionalized pyridines and dihydropyridines, see: Litvinov, V. P. Usp. Khim. 2003, 72, 75-92.
26. Erian, A. W. Chem. Rev. 1993, 93, 1991-2005.
27. For a recent review, see: Lavilla, R. J. Chem. Soc., Perkin Trans. 1 2002, 1141-1156.
28. Wallace, D. J.; Gibb, A. D.; Cottrell, I. F.; Kennedy, D. F.; Brands, K. M. J.; Dolling, U. H. Synthesis 2001, 1784-1789.
29. Meyers, A. I.; Ritter, J. J. J. Org. Chem. 1958, 23, 1918-1922.
30. See: Mashraqui, S. H.; Karnik, M. A. Tetrahedron Lett. 1998, 39, 4895-4898 and references therein.
31. Zhu, X.-Q.; Zou, H.-L.; Yuan, P.-W.; Liu, Y.; Cao, L.; Cheng, J.-P. J. Chem. Soc., Perkin Trans. 2 2000, 1857-1861.
32. For a review discussing 1,4-dihydropyridines as privileged structures, see: Triggle, D. J. Cell. Mol. Neurobiol. 2003, 23, 293-303.
33. For a review of structure-activity relationship studies, see: Goldmann, S.; Stoltefuss, J. Angew. Chem., Int. Ed. 1991, 30, 1559-1578.
34. Hobbs, F. W., Jr. PCT Int. Appl. WO 2000056706 A1 20000928, 2000.
35. Duncia, J. V. et al. Bioorg. Med. Chem. Lett. 1998, 8, 2839-2844.